v3.26.3
Shareholder’s Equity - Schedule of Activities Share Options (Details) - USD ($)
12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Schedule of Activities Share Options [Abstract]      
Number of Share Options, Outstanding Beginning Balance 24,490,506 28,673,014  
Weighted Average Exercise Price, Outstanding Beginning Balance $ 0.68 $ 0.26  
Weighted Average Grant-date Fair value ,Outstanding Beginning Balance $ 0.4 $ 0.15  
Weighted Average Remaining Contractual Term, Outstanding Balance 5 years 2 months 1 day 6 years 1 month 28 days 7 years 21 days
Aggregate Intrinsic Value, Outstanding Beginning Balance $ 117,555,247 $ 440,464,693
Number of Share Options, Granted   592,230  
Weighted Average Exercise Price, Granted   $ 17.4  
Weighted Average Grant-date Fair value, Granted   $ 10.39  
Weighted Average Remaining Contractual Term, Granted   10 years  
Aggregate Intrinsic Value, Granted    
Number of Share Options, Expired, forfeited or cancelled (in Shares) (2,035,736) (4,774,738)  
Weighted Average Exercise Price, Expired, forfeited or cancelled $ 0.25 $ 0.25  
Weighted Average Grant-date Fair value, Expired, forfeited or cancelled $ 0.14 $ 0.14  
Weighted Average Remaining Contractual Term, Expired, forfeited or cancelled 5 years 6 months 18 days 6 years 6 months 18 days  
Aggregate Intrinsic Value, Expired, forfeited or cancelled (in Dollars)  
Weighted Average Exercise Price, Exercised $ 0.25    
Weighted Average Grant-Date Fair Value, Exercised $ 0.14    
Weighted Average Remaining Contractual Term, Exercised 5 years 18 days    
Aggregate Intrinsic Value, Exercised    
Share-Based Compensation Arrangement by Share-Based Payment Award, Repurchased [1] (123,498)    
Weighted Average Exercise Price, Repurchased [1] $ 0.59    
Weighted Average Grant-date Fair value, Repurchased [1] $ 0.42    
Weighted Average Remaining Contractual Term, Repurchased [1] 5 years 3 months 21 days    
Aggregate Intrinsic Value, Expired, Repurchased [1]    
Number of Share Options, Outstanding Ending Balance 21,921,026 24,490,506 28,673,014
Weighted Average Exercise Price, Ending Balance $ 0.73 $ 0.68 $ 0.26
Weighted Average Grant-date Fair value , Ending Balance $ 0.43 $ 0.4 $ 0.15
Aggregate Intrinsic Value, Outstanding Ending Balance $ 117,555,247 $ 440,464,693
Number of Share Options, Exercisable 21,476,854    
Weighted Average Exercise Price, Exercisable $ 0.38    
Weighted Average Grant-date Fair value , Exercisable $ 0.23    
Weighted Average Remaining Contractual Term, Exercisable 5 years 1 month 2 days    
Aggregate Intrinsic Value, Exercisable $ 122,578,832    
Number of Share Options, Vested and Expected to Vest (in Shares) 21,921,026    
Weighted Average Exercise Price, Vested and Expected to Vest $ 0.73    
Weighted Average Grant-date Fair value, Vested and Expected to Vest $ 0.43    
Weighted Average Remaining Contractual Term, Vested and Expected to Vest 5 years 2 months 1 day    
Aggregate Intrinsic Value, Vested and Expected to Vest (in Dollars)    
Exercise of share option (in Shares) (410,246)    
[1] In May and June 2026, the Company repurchased 123,498 vested stock options from two independent directors and one former independent director, which had been previously granted through its 2021 Share Option Plan.